Novo Nordisk taps Aspen to help produce insulin for Africa

Novo Nordisk, following a similar move by its diabetes rival Eli Lilly, is teaming up with Aspen Pharmacare to shore up insulin supplies in Africa, which currently imports more than 80% of its medicine.